Key facts
- Notable investors include VentureSouq.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Avrio
- ·The full record, as it builds
Funding rounds
No funding rounds for Avrio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Avrio
Developer of a healthcare financial and clinic management software platform designed to streamline insurance claim processing and healthcare operations. The company's platform integrates clinical, administrative, and financial management capabilities within a unified system that supports patient booking, clinical documentation, multi-branch monitoring, and insurance claim submission, while incorporating artificial intelligence to analyze healthcare data, reduce claim rejection rates, and support clinical decision making, alongside automated revenue cycle management and mechanisms that convert approved insurance claims into upfront capital to address payment delays and liquidity constraints, enabling healthcare providers and clinics to improve operational efficiency, accelerate reimbursements, and stabilize cash flow.
- Sector
- Healthcare
- HQ
- Riyadh, Saudi Arabia
- Founded
- 2021
- Employees
- 11
- Website
- avrio.sa/
- Ownership
- Privately Held (backing)
Avrio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Avrio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Avrio in its N-PORT filings yet. We sweep new filings monthly.